Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease (Aug 2022)
SGLT2 Inhibitors—A Medical Revelation: Molecular Signaling of Canagliflozin Underlying Hypertension and Vascular Remodeling
Abstract
No abstracts available.Keywords